Ocular Therapeutix
Peter Jarrett has extensive experience in the field of biomaterials R&D, with roles such as Chief Scientific Officer at Ocular Therapeutix. Peter holds a Ph.D. in Polymer Science from the University of Connecticut and a B.A. in Chemistry from Connecticut College. Their work has focused on ocular sustained drug delivery from bioresorbable hydrogel depots.
This person is not in any offices
Ocular Therapeutix
2 followers
Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies for diseases and conditions of the eye using its hydrogel platform technology. The Company's bioresorbable hydrogel ba...